MCID: SML034
MIFTS: 39

Small Cell Neuroendocrine Carcinoma

Categories: Cancer diseases, Neuronal diseases, Respiratory diseases

Aliases & Classifications for Small Cell Neuroendocrine Carcinoma

MalaCards integrated aliases for Small Cell Neuroendocrine Carcinoma:

Name: Small Cell Neuroendocrine Carcinoma 12 14
Carcinoma, Small Cell 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0050875

Summaries for Small Cell Neuroendocrine Carcinoma

MalaCards based summary : Small Cell Neuroendocrine Carcinoma, also known as carcinoma, small cell, is related to urinary bladder small cell neuroendocrine carcinoma and gallbladder small cell carcinoma. An important gene associated with Small Cell Neuroendocrine Carcinoma is SYP (Synaptophysin), and among its related pathways/superpathways are Endometrial cancer and Pathways in cancer. The drugs Cisplatin and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include lung, cervix and prostate.

Related Diseases for Small Cell Neuroendocrine Carcinoma

Diseases in the Large Cell Neuroendocrine Carcinoma family:

Small Cell Neuroendocrine Carcinoma

Diseases related to Small Cell Neuroendocrine Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 310)
# Related Disease Score Top Affiliating Genes
1 urinary bladder small cell neuroendocrine carcinoma 33.9 CHGA ENO2 SYP
2 gallbladder small cell carcinoma 31.5 CHGA ENO2 NCAM1 SYP
3 small cell cancer of the lung 30.2 CDKN2A CHGA ENO2 KIT NCAM1 SYP
4 adenocarcinoma 29.8 CDKN2A KIT TP53
5 large cell neuroendocrine carcinoma 28.8 CHGA ENO2 KIT NCAM1 SYP
6 merkel cell carcinoma 28.1 CHGA ENO2 KIT NCAM1 SYP TP53
7 lung cancer 27.5 CDKN2A CHGA ENO2 KIT NCAM1 SYP
8 colon small cell carcinoma 11.2
9 esophagus small cell carcinoma 11.2
10 ampulla of vater small cell carcinoma 11.2
11 ureter small cell carcinoma 10.5 CHGA SYP
12 adenoma of the pancreas 10.5 CHGA SYP
13 acinar cell cystadenocarcinoma 10.5 CHGA SYP
14 peritoneal serous adenocarcinoma 10.5 CHGA SYP
15 primary hepatic neuroendocrine carcinoma 10.5 CHGA SYP
16 gastrointestinal neuroendocrine tumor 10.5 CHGA SYP
17 chordoid meningioma 10.5 CHGA SYP
18 intracranial primitive neuroectodermal tumor 10.4 CHGA ENO2
19 pulmonary sclerosing hemangioma 10.4 CHGA SYP
20 epithelioid malignant peripheral nerve sheath tumor 10.4 CHGA ENO2
21 pancreatoblastoma 10.4 CHGA SYP
22 goblet cell carcinoid 10.4 CHGA ENO2
23 acute thyroiditis 10.4 CHGA ENO2
24 malignant sertoli cell tumor 10.4 ENO2 SYP
25 ureter, cancer of 10.4 CHGA SYP
26 nodular ganglioneuroblastoma 10.4 CHGA ENO2
27 sinonasal undifferentiated carcinoma 10.4 ENO2 SYP
28 sensory organ benign neoplasm 10.4 ENO2 SYP
29 tanycytic ependymoma 10.4 CHGA SYP
30 middle ear adenoma 10.4 ENO2 SYP
31 non-functioning pancreatic endocrine tumor 10.4 CHGA SYP
32 pancreatic somatostatinoma 10.4 ENO2 SYP
33 papillary tumor of the pineal region 10.4 ENO2 SYP
34 respiratory system benign neoplasm 10.4 CHGA ENO2
35 ovarian carcinosarcoma 10.4 ENO2 SYP
36 subependymal glioma 10.4 ENO2 SYP
37 extraosseous chondrosarcoma 10.4 ENO2 SYP
38 benign ependymoma 10.4 ENO2 SYP
39 malignant teratoma 10.4 ENO2 SYP
40 astroblastoma 10.4 ENO2 SYP
41 pancreatic cystadenocarcinoma 10.4 CHGA SYP
42 somatostatinoma 10.4 CHGA ENO2
43 binswanger's disease 10.4 CHGA SYP
44 pineal gland cancer 10.4 ENO2 SYP
45 melanotic neuroectodermal tumor 10.4 ENO2 SYP
46 mucinous ovarian cystadenoma 10.4 ENO2 SYP
47 lung combined type small cell carcinoma 10.4 NCAM1 SYP
48 spinal canal and spinal cord meningioma 10.4 CHGA ENO2
49 bone benign neoplasm 10.4 ENO2 SYP
50 pancreatic endocrine carcinoma 10.4 NCAM1 SYP

Graphical network of the top 20 diseases related to Small Cell Neuroendocrine Carcinoma:



Diseases related to Small Cell Neuroendocrine Carcinoma

Symptoms & Phenotypes for Small Cell Neuroendocrine Carcinoma

Drugs & Therapeutics for Small Cell Neuroendocrine Carcinoma

Drugs for Small Cell Neuroendocrine Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 83)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
2
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 38904 498142
3
Doxycycline Approved, Investigational, Vet_approved Phase 3 564-25-0 54671203
4
Povidone-iodine Approved Phase 3 25655-41-8
5
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
6
Tremelimumab Investigational Phase 3,Phase 2 745013-59-6
7 Antibodies Phase 3,Phase 2
8 Antibodies, Monoclonal Phase 3,Phase 2
9 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
10 Immunoglobulins Phase 3,Phase 2
11 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
12 Anti-Bacterial Agents Phase 3,Phase 2
13 Anti-Infective Agents Phase 3,Phase 1
14 Antimalarials Phase 3
15 Antiparasitic Agents Phase 3
16 Antiprotozoal Agents Phase 3
17 Etoposide phosphate Phase 3,Phase 2,Phase 1
18
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
19
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
20
Lenograstim Approved, Investigational Phase 2 135968-09-1
21
Paclitaxel Approved, Vet_approved Phase 2,Phase 1 33069-62-4 36314
22
Topotecan Approved, Investigational Phase 2,Phase 1 119413-54-6, 123948-87-8 60700
23
Cetuximab Approved Phase 2,Phase 1 205923-56-4 56842117 2333
24
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
25
Fluorouracil Approved Phase 2 51-21-8 3385
26
Ifosfamide Approved Phase 2 3778-73-2 3690
27
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
28
Olaparib Approved Phase 2 763113-22-0 23725625
29
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
30
Camptothecin Experimental Phase 2 7689-03-4
31
Veliparib Investigational Phase 2,Phase 1 912444-00-9 11960529
32
Docetaxel Approved May 1996, Investigational Phase 2 114977-28-5 148124 9877265
33
Doxil Approved June 1999 Phase 2 31703
34
Cediranib Investigational Phase 2 288383-20-0 9933475
35 topoisomerase I inhibitors Phase 2,Phase 1
36 Albumin-Bound Paclitaxel Phase 2,Phase 1
37 Alkylating Agents Phase 2
38 Antimitotic Agents Phase 2,Phase 1
39 Antirheumatic Agents Phase 2
40 Immunosuppressive Agents Phase 2,Phase 1
41 Adjuvants, Immunologic Phase 2
42 Poly(ADP-ribose) Polymerase Inhibitors Phase 2,Phase 1
43 Antibiotics, Antitubercular Phase 2
44 Antimetabolites Phase 2,Phase 1
45 Antimetabolites, Antineoplastic Phase 2,Phase 1
46 Protein Kinase Inhibitors Phase 2,Phase 1
47 Isophosphamide mustard Phase 2 0
48 Pharmaceutical Solutions Phase 2
49 Dermatologic Agents Phase 1, Phase 2
50 Keratolytic Agents Phase 1, Phase 2

Interventional clinical trials:

(show all 43)

# Name Status NCT ID Phase Drugs
1 A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion Recruiting NCT02583282 Phase 3
2 Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) Recruiting NCT03043872 Phase 3 Durvalumab;Tremelimumab;Carboplatin;Cisplatin;Etoposide
3 Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer Withdrawn NCT00006344 Phase 3
4 Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer Unknown status NCT01635400 Phase 2 Irinotecan
5 Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer Unknown status NCT01158248 Phase 2 cisplatin
6 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. Completed NCT00003943 Phase 2 carboplatin;cyclophosphamide;paclitaxel;topotecan hydrochloride
7 Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer Completed NCT00907569 Phase 2
8 ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer Completed NCT00309959 Phase 2 Paclitaxel Albumin-Stabilized Nanoparticle Formulation
9 Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer Completed NCT00217633 Phase 2
10 Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Completed NCT01266447 Phase 2 Topotecan Hydrochloride;Veliparib
11 Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Completed NCT00101192 Phase 2 cisplatin
12 Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Completed NCT00276796 Phase 2 cisplatin;paclitaxel;topotecan hydrochloride
13 Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Completed NCT00003379 Phase 1, Phase 2 cisplatin;paclitaxel
14 Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium Recruiting NCT00756639 Phase 2
15 Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Cancers Recruiting NCT02487095 Phase 1, Phase 2 Topotecan;VX-970
16 Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC) Recruiting NCT02995187 Phase 2 Apatinib Mesylate tablet
17 A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Recruiting NCT02601950 Phase 2 Tazemetostat
18 Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients Recruiting NCT02099188 Phase 2 Cisplatin;Docetaxel;5-fluorouracil;Etoposide;Adriamycin;Ifosfamide;Leucovorin
19 Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients Recruiting NCT02099175 Phase 2 Cisplatin;Docetaxel;5-fluorouracil;Etoposide;Adriamycin;Ifosfamide;Leucovorin
20 A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer Recruiting NCT02937818 Phase 2 Durvalumab and Tremelimumab;AZD1775 and carboplatin (CBPT)
21 Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT02893917 Phase 2 Cediranib;Olaparib
22 Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer Active, not recruiting NCT01642251 Phase 1, Phase 2 Cisplatin;Etoposide;Veliparib
23 Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Active, not recruiting NCT00416455 Phase 1, Phase 2 ferumoxtran-10
24 ADXS11-001 High Dose HPV+ Cervical Cancer Active, not recruiting NCT02164461 Phase 1, Phase 2
25 Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer Terminated NCT00003496 Phase 2 Antineoplaston therapy (Atengenal + Astugenal)
26 Hypofractionated Radiotherapy for Small Cell Lung Cancer Completed NCT00469222 Phase 1
27 Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer Completed NCT00466232 Phase 1 Topotecan;Sorafenib
28 Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma Completed NCT00580320 Phase 1 Dacarbazine and bortezomib
29 Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Completed NCT00104910 Phase 1 Cisplatin
30 Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer Completed NCT00068549 Phase 1 Gemcitabine Hydrochloride;Cisplatin
31 Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma Active, not recruiting NCT02881125 Phase 1 Nortriptyline Hydrochloride;Paclitaxel
32 Cone Beam CT Scanning in Lung and Bladder Cancer. Completed NCT00469066
33 Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment Completed NCT03419286
34 Concurrent Chemo-radiation Form NSCLC to a Individualized MLD Completed NCT00572325
35 Radiotherapy for NSCLC to a Individualized MLD Completed NCT00573040
36 Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes Completed NCT00460356
37 Collecting Tumor Samples From Patients With Gynecological Tumors Completed NCT00897442
38 Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors Recruiting NCT02146170
39 International Ovarian & Testicular Stromal Tumor Registry Recruiting NCT01970696
40 Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen Recruiting NCT02331290
41 Mass Spectral Fingerprinting in Lung Cancer Recruiting NCT02781857
42 Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix Recruiting NCT01606293
43 Circulating Tumor DNA in Patients at High Risk for Lung Cancer Terminated NCT02715102

Search NIH Clinical Center for Small Cell Neuroendocrine Carcinoma

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Genetic Tests for Small Cell Neuroendocrine Carcinoma

Anatomical Context for Small Cell Neuroendocrine Carcinoma

MalaCards organs/tissues related to Small Cell Neuroendocrine Carcinoma:

38
Lung, Cervix, Prostate, Lymph Node, Brain, Tongue, Thyroid

Publications for Small Cell Neuroendocrine Carcinoma

Articles related to Small Cell Neuroendocrine Carcinoma:

(show top 50) (show all 145)
# Title Authors Year
1
Small cell neuroendocrine carcinoma of nose and paranasal sinuses: The Shaukat Khanum Memorial Cancer Hospital experience and review of literature. ( 29371736 )
2018
2
Small cell neuroendocrine carcinoma of the nasopharynx: a rare case report. ( 28536685 )
2017
3
Syndrome of inappropriate antidiuretic hormone associated with rectal small cell neuroendocrine carcinoma: a case report. ( 28852457 )
2017
4
Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix. ( 28954697 )
2017
5
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix. ( 28754175 )
2017
6
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate. ( 28621319 )
2017
7
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma. ( 28529747 )
2017
8
Positron emission tomography/computed tomography imaging of adrenocorticotropic hormone-producing small-cell neuroendocrine carcinoma of the cervix. ( 28106911 )
2017
9
Small cell neuroendocrine carcinoma of the paranasal sinus with intraoral involvement: Report of a rare case and review of the literature. ( 28932042 )
2017
10
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report. ( 28174665 )
2017
11
Acute renal failure due to small cell neuroendocrine carcinoma of the left kidney: A case report. ( 29113255 )
2017
12
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. ( 27823771 )
2017
13
Cytological features of adenocarcinoma admixed with small cell neuroendocrine carcinoma of the uterine cervix. ( 28603541 )
2017
14
Primary small cell neuroendocrine carcinoma of the breast - A case report and review of the literature. ( 28734185 )
2017
15
Extra-pulmonary primary small-cell neuroendocrine carcinoma arising from the duodenum: rare tumor, unusual location. ( 29225868 )
2017
16
Report: Small cell neuroendocrine carcinoma (SCNEC) of the tongue: A case report. ( 28671105 )
2017
17
Postradiotherapy small cell neuroendocrine carcinoma of base of tongue: An unusual clinical and site presentation. ( 27853043 )
2017
18
An Extremely Rare Case of Advanced Metastatic Small Cell Neuroendocrine Carcinoma of Sinonasal Tract. ( 27529044 )
2016
19
(68)Ga-DOTANOC PET-CT in a rare case of metastatic small cell neuroendocrine carcinoma of paranasal sinus. ( 26656431 )
2016
20
Ampullary carcinosarcoma with osteosarcomatous, small cell neuroendocrine carcinoma and conventional adenocarcinoma components; First report. ( 27640104 )
2016
21
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma. ( 26832214 )
2016
22
Mediastinum primary small cell neuroendocrine carcinoma. ( 27095946 )
2016
23
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH. ( 27077720 )
2016
24
Small cell neuroendocrine carcinoma of tracheostomy site in a patient with a history of juvenile laryngeal papillomatosis. ( 27507691 )
2016
25
Early Detection of Bone Metastasis in Small Cell Neuroendocrine Carcinoma of the Cervix by 68Ga-DOTATATE PET/CT Imaging. ( 28005640 )
2016
26
Small cell neuroendocrine carcinoma of the endometrium with pulmonary metastasis: A clinicopathologic study of a case and a brief review of the literature. ( 26900464 )
2016
27
Thymic Small Cell Neuroendocrine Carcinoma Displayed on 18F-FDG PET/CT Imaging. ( 26673232 )
2016
28
Colonic small cell neuroendocrine carcinoma in a patient with long-standing ulcerative colitis treated with azathioprine. ( 27103360 )
2016
29
Small-cell Neuroendocrine Carcinoma Associated with Non Adenoma-like Raised Lesion in a Patient with Long-standing Ulcerative Colitis. ( 26912579 )
2016
30
Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma. ( 27481176 )
2016
31
Sinonasal small cell neuroendocrine carcinoma: a systematic review of 80 patients. ( 26880574 )
2016
32
A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications. ( 26254373 )
2015
33
Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation? ( 26530293 )
2015
34
Small cell neuroendocrine carcinoma of the posterior tongue. ( 26458628 )
2015
35
PD-L1 expression in small cell neuroendocrine carcinomas. ( 25582496 )
2015
36
A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix. ( 25500455 )
2015
37
Primary small cell neuroendocrine carcinoma of the oral cavity: A case report and review of the literature. ( 26622589 )
2015
38
Metastatic Small-Cell Neuroendocrine Carcinoma Simulating Circumscribed Choroidal Hemangioma. ( 27171748 )
2015
39
Small cell neuroendocrine carcinoma of the esophagus. ( 25645990 )
2015
40
The CT and MRI observations of small cell neuroendocrine carcinoma in paranasal sinuses. ( 25888820 )
2015
41
p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma. ( 25512615 )
2015
42
A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal. ( 26198995 )
2015
43
Primary Ureteral Thyroid Transcription Factor 1-Positive Small Cell Neuroendocrine Carcinoma: Case Report and Review of the Literature. ( 26162396 )
2015
44
Small cell neuroendocrine carcinoma of larynx: case series and literature review. ( 26173932 )
2015
45
Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix. ( 26186071 )
2015
46
Small cell neuroendocrine carcinoma of the ethmoid sinus revealed by syndrome of inappropriate antidiuretic hormone secretion. ( 26048029 )
2015
47
Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. ( 25574101 )
2015
48
Small cell neuroendocrine carcinoma of the endometrium: AA clinicopathologic study of six cases. ( 25286790 )
2014
49
Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. ( 26075998 )
2014
50
Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by (18)F-FDG PET/CT. ( 25018134 )
2014

Variations for Small Cell Neuroendocrine Carcinoma

Copy number variations for Small Cell Neuroendocrine Carcinoma from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 226170 7 55086725 55275030 Not increased EGFR Small cell neuroendocrine carcinoma

Expression for Small Cell Neuroendocrine Carcinoma

Search GEO for disease gene expression data for Small Cell Neuroendocrine Carcinoma.

Pathways for Small Cell Neuroendocrine Carcinoma

GO Terms for Small Cell Neuroendocrine Carcinoma

Cellular components related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mast cell granule GO:0042629 8.62 CHGA KIT

Biological processes related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mast cell degranulation GO:0043303 9.32 CHGA KIT
2 replicative senescence GO:0090399 9.26 CDKN2A TP53
3 somatic stem cell division GO:0048103 9.16 CDKN2A KIT
4 mast cell chemotaxis GO:0002551 8.96 CHGA KIT
5 mast cell cytokine production GO:0032762 8.62 CHGA KIT

Molecular functions related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 disordered domain specific binding GO:0097718 8.62 CDKN2A TP53

Sources for Small Cell Neuroendocrine Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....